BioMérieux S.A.
BIM
株式のランク
#1761
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
株価
$103.91
時価総額
$12.23B
変化（1日）
0.86%
変化（1年）
-19.74%
国
FR
取引 BioMérieux S.A. (BIM)
カテゴリー
Healthcare
BioMérieux S.A.（BIM）のP/S比率
October 2026 時点のP/S比率 TTM: 2.53
BioMérieux S.A. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 2.53 です。2023 年末時点でのP/S比率は 3.23 でした。
BioMérieux S.A. の P/S 比率の履歴（2005 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 2.53 | -17.45% |
| 2024 | 3.06 | -5.24% |
| 2023 | 3.23 | 0.44% |
| 2022 | 3.22 | -26.45% |
| 2021 | 4.38 | 0.06% |
| 2020 | 4.37 | 24.59% |
| 2019 | 3.51 | 25.46% |
| 2018 | 2.80 | -26.81% |
| 2017 | 3.82 | 43.98% |
| 2016 | 2.65 | 20.26% |
| 2015 | 2.21 | 10.85% |
| 2014 | 1.99 | 4.99% |
| 2013 | 1.90 | 4.92% |
| 2012 | 1.81 | 18.41% |
| 2011 | 1.53 | -28.88% |
| 2010 | 2.15 | -18.52% |
| 2009 | 2.63 | 23.58% |
| 2008 | 2.13 | -27.38% |
| 2007 | 2.94 | 49.35% |
| 2006 | 1.97 | 11.04% |
| 2005 | 1.77 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 5.37 | 112.66% |
US
|
|
| 6.29 | 149.09% |
US
|
|
| 21.02 | 732.12% |
US
|
|
| - | - |
CN
|
|
| 6.67 | 163.90% |
US
|
